logo

ANIP

ANI PharmaceuticalsยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

ANIP Profile

Ani Pharmaceuticals, Inc.

A diversified biopharmaceutical company that develops and manufactures branded and generic prescription pharmaceuticals

Pharmaceutical
--
11/05/2007
NASDAQ Stock Exchange
897
12-31
Common stock
210 Main Street West, Baudette, Minnesota 56623
--
ANI Pharmaceuticals, Inc., was founded in Delaware in April 2001. The Company is an integrated specialty pharmaceutical company dedicated to delivering value to the Company's customers by developing, manufacturing and selling high-quality branded and generic prescription drugs. The company focuses on niche and high-entry opportunities, including controlled substances, anticancer (oncolytic drugs), hormones and steroids, and complex formulations. The company's two pharmaceutical plants in Baudette, Minnesota are capable of producing oral solid dose products, as well as liquid and topical, controlled substances and effective products that must be manufactured in a fully enclosed environment. The company's strategy is to use its assets to develop, acquire, manufacture and sell branded and generic specialty prescription drugs.